Supplemental breast cancer screening in women with dense breasts and negative mammography: a systematic review and meta-analysis

H Hussein, E Abbas, S Keshavarzi, R Fazelzad… - Radiology, 2023 - pubs.rsna.org
Background The best supplemental breast cancer screening modality in women at average
risk or intermediate risk for breast cancer with dense breast and negative mammogram …

systematic review on electrochemical biosensing of breast cancer miRNAs to develop alternative DCIS diagnostic tool

S Sornambikai, H Amir, G Bhuvaneshwari… - ECS Sensors …, 2022 - iopscience.iop.org
Till date, no systematic review is conducted on electrochemical biosensing of multiplexed
breast cancer miRNAs to identify their suitability as an alternative diagnostic tool for ductal …

Prediction of upstaging in ductal carcinoma in situ based on mammographic radiomic features

R Hou, LJ Grimm, MA Mazurowski, JR Marks, LM King… - Radiology, 2022 - pubs.rsna.org
Background Improving diagnosis of ductal carcinoma in situ (DCIS) before surgery is
important in choosing optimal patient management strategies. However, patients may harbor …

Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?

F Galati, V Rizzo, G Moffa, C Caramanico… - European Radiology …, 2022 - Springer
Background Breast cancer (BC) includes different pathological and molecular subtypes. This
study aimed to investigate whether multiparametric magnetic resonance imaging (mpMRI) …

Breast MRI: clinical indications, recommendations, and future applications in breast cancer diagnosis

D Wekking, M Porcu, P De Silva, L Saba… - Current oncology …, 2023 - Springer
Abstract Purpose of Review This article aims to provide an updated overview of the
indications for diagnostic breast magnetic resonance imaging (MRI), discusses the available …

[HTML][HTML] Non-mass enhancement breast lesions: MRI findings and associations with malignancy

G Liu, Y Li, SL Chen, Q Chen - Annals of Translational Medicine, 2022 - ncbi.nlm.nih.gov
Background Magnetic resonance imaging (MRI) is a multi-sequence imaging technique.
Although MRI is the most sensitive method for detecting breast cancer, it is limited in …

Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in …

M Kaiyin, T Lingling, T Leilei, L Wenjia, J Bin - Breast Cancer Research …, 2023 - Springer
Objective Breast cancer patients receiving neoadjuvant therapy (NAT) are in need of a more
patient-friendly imaging modality such as contrast-enhanced mammography (CEM) for …

Artificial intelligence (AI) in breast imaging: A scientometric umbrella review

XJ Tan, WL Cheor, LL Lim, KS Ab Rahman, IH Bakrin - Diagnostics, 2022 - mdpi.com
Artificial intelligence (AI), a rousing advancement disrupting a wide spectrum of applications
with remarkable betterment, has continued to gain momentum over the past decades. Within …

Ultra-high b-value diffusion-weighted imaging-based abbreviated protocols for breast cancer detection

S Ohlmeyer, FB Laun, S Bickelhaupt, T Palm… - Investigative …, 2021 - journals.lww.com
Objectives Contrast-enhanced (CE) magnetic resonance imaging (MRI) is the most effective
imaging modality for breast cancer detection. A contrast agent–free examination technique …

Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI‐Based Radiomics

M Hong, S Fan, Z Yu, C Gao, Z Fang… - Journal of Magnetic …, 2023 - Wiley Online Library
Background About 20%–40% of patients diagnosed with ductal carcinoma in situ (DCIS) by
core needle biopsy (CNB) will develop invasive cancer at the time of excision. Improving the …